Clvs Stock Forecast 2025Clovis Oncology Stock Forecast 05-18-2023. Clorox stock monthly and weekly forecasts. 00000098 USD 5 Year Forecast: 0 USD. However, there are some general principles that can be followed in order to improve the accuracy of stock price predictions. Nokia Corp Stock Forecast, Predictions & Price Target. Clovis Oncology Free Cash Flow Forecast for 2023 - 2025 - 2030. (BTTX) Stock Forecast & Price Target. Weaker technical forecast for Eyenovia Inc. Highest Price Target ― Average Price Target ―. The Clorox Company stock trend is positive. 00%) (As of 05/9/2023 ET) Today's Range $0. The stock was forecast to remain at 0. 88 million shs Market Capitalization $11. Stock Lists Headlines About NASDAQ:CLVS Clovis Oncology (CLVS) Price Target & Analyst Ratings Notice: This company has been marked as potentially delisted and may not be actively trading. No one predicted CLVS this week yet. CLVS share price has been in a bear cycle for the past year. CLVT share price has been in a bear cycle for the past year. 767 Stock Info General Ceo: Benjamin Cowart Exchange: NASDAQ Industry 2: Petroleum Refineries Sector 2: Manufacturing Type: Common Stock Website: www. 37% plunged 75% Wednesday, after the Colorado-based biotech said it will not have sufficient liquidity to maintain operations beyond January of 2023. NASDAQ:XELA Exela Technologies (XELA) Stock Forecast, Price & News $0. 77 million shs Average Volume 143. Clovis Oncology stock slides 75% after biotech warns it will run out of cash by January of 2023 Clovis Oncology Inc. Positive dynamics for Clovis Oncology shares will prevail with possible. Stock Forecast, Price & News. as stock downgraded to Hold/Accumulate. 43 million shs Average Volume 8. The company 6 months ago - Market Watch. Clovis Oncology (CLVS) Stock Forecast, Price & News Notice: This company has been marked as potentially delisted and may not be actively trading. Clorox company info Forecasting 52 Week High: 182. The median estimate represents a +13. 00 and a low forecast of $4. The current enterprise value of the company is $811 million. Stock Price Forecast The 1 analysts offering 12-month price forecasts for Clovis Oncology Inc have a median target of 2. 07382 USD 5 Year Forecast: 0 USD Agilent Technologies info. The average Better Therapeutics stock price prediction forecasts a potential upside of 649. The average Clovis Oncology stock forecast 2025 represents a 407. 49% Upside) Based on 2 Wall Street analysts offering 12 month price targets for Gevo in the last 3 months. 00 and a low forecast of $5. Compare Today's Range N/A 50-Day Range $0. The analysts did not provide CLVS stock price prediction for 2025. Clarivate stock monthly and weekly forecasts. CLVS stock returns are also predicted based on historical data. 78 Forecast 2025 $4. The average price target represents a 177. CuriosityStream (CURI) Stock Forecast & Price Target. Clovis Oncology Stock Forecast 05-18-2023. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. The average price target is ― with. Clovis Oncology (CLVS) Stock Forecast, Price & News Notice: This company has been marked as potentially delisted and may not be actively trading. Stock Price, Quote & News ">Clovis Oncology, Inc. 09 Clovis Oncology Stock Forecast 05-19-2023. Clovis Oncology (CLVS) stock forecast for 2025 Last update: April 21, 2023 (06:26) Sector: Healthcare The share price of Clovis Oncology, Inc. Stock Stat Historical data: Market Cap (Previous Close): 10. The average price target is ― with a high forecast of ― and a low forecast of ―. Based on 1 Wall Street analysts offering 12 month price targets for Clovis Oncology in the last 3 months. If the price is below the blue line, this is a buy signal for the CLVS stock. During the last trading day the stock fluctuated 8. The average price target is $11. CLVS stock forecast for 2023. Clovis Oncology CLVS Stock Forecast & Price Prediction 2025, 2030. Clovis Oncology (CLVS) Price Target & Analyst Ratings Notice: This company has been marked as potentially delisted and may not be actively trading. The best long-term & short-term Caladrius Biosciences share price prognosis for 2023, 2024, 2025, 2026, 2027, 2028 with daily CLBS exchange price projections: monthly and daily opening, closing, maximum and minimum stock price outlook with smart technical analysis Markets Forecast Crypto Forecasts Top 5 Crypto forecasts Bitcoin forecast. us">EYEN Stock Price Forecast. Clovis Oncology (CLVS) stock Forecast for 2022 – 2026. us">MNKD Stock Price Forecast. The Clovis Oncology stock forecast for tomorrow is $ 0. CLVS : Clovis Oncology stock forecast, predictions, and share price target for 2022, 2023 (1 year) to 2025 - 2027 (5 year) to 2030, and 2032 (10 year) with Revenue and EPS Prognosis by Technical Analysis From AI system, total return is 2366. 50 and a low forecast of $2. Forecast data: 52 Week High: 10. 60 million P/E Ratio N/A Dividend Yield N/A. (Updated on May 10, 2023) Buy or Hold candidate since 2023-03-23 Gain 45. 00 with a high forecast of $9. The company has a commitment for up to $75 5 months ago - Market Watch. (CLVS) now CLVS What analysts predict: $ 52-week High/Low: $ / $ 50/200 Day Moving Average: $ / $ This figure corresponds to the Average Price over the previous 50/200 days. stock forecast for 2023 – 2027. 49% change from the last price of $1. 39 million P/E Ratio N/A Dividend Yield N/A Price Target N/A. CLVS Stock 12 Months Forecast. 935 USD 5 Year Forecast: 237. 35 million shs Average Volume 1. Clovis Oncology Free Cash Flow Forecast for 2023 - 2025 - 2030 In the last three years, Clovis Oncology's Free Cash Flow has fallen from $-375. com Country Name: USA Sector: Energy Industry: Oil &. 89% Upside) Based on 3 Wall Street analysts offering 12 month price targets for Better Therapeutics, Inc. Analyst Consensus: n/a Analyst Ratings There are currently no analyst ratings available for CLVSQ. Clovis Oncology (CLVS) Stock Forecast & Price Prediction 2025, …. CLWT share price has been in a bull cycle for the past year. Recommendation Trends No data available Financial Forecast Annual Quarterly Export. The current enterprise value of the company is $811 million. Overview Forecast Earnings Dividend Ownership Analyst price target for NOK All Analysts Top Analysts Based on 1 analyst offering 12 month price targets for Nokia Corp. Clovis Oncology Stock Forecast Updated Wed, Apr 19, 2023 3m (0%) 12m (-93. Euro Tech Holdings company info Forecasting 52 Week High: 2. CLVS : Clovis Oncology stock forecast 2022. Clarivate Plc (CLVT) share price prediction for 2023, 2024, 2025, 2026 and 2027. Clarivate company info Forecasting 52 Week High: 16. PBG was not significantly reduced among groups. Gevo (GEVO) Stock Forecast & Price Target. National Cinemedia Stock Forecast, "N. 00%) (As of 05/8/2023 ET) Compare Today's Range $0. US Stock Forecast Clovis Oncology Inc Stock Predictons by days: 2022 Search Stock, FX pair, Crypto, or Commodity Clovis Oncology Inc Stock Forecast and Price Prognosis Data for 2022 History Forecast Charts Data Market Q&A Comments Buy CRYPTO Get 12% interest on Crypto Select other stock. Forecasts Financials Shareholders Competitors Stock Price Forecast The 1 analysts offering 12-month price forecasts for Clovis Oncology Inc have a median target of 2. The best long-term & short-term Caladrius Biosciences share price prognosis for 2023, 2024, 2025, 2026, 2027, 2028 with daily CLBS exchange price projections: monthly and daily opening, closing, maximum and minimum stock price outlook with smart technical analysis Markets Forecast Crypto Forecasts Top 5 Crypto forecasts Bitcoin forecast. Blue sky scenario: Clovis occupies 75% of the $5 billion (or higher at 27% CAGR) per year PARP inhibitor market in 2025 or after (highly possible with) Lucitanib + Rubraca + Opdivo combination). 94% fell 10% in premarket trade Monday, after the biotech filed for Chapter 11 bankruptcy and said it would sell assets. Where will Apple Stock Be In 1 Year? – Financhill. Euro Tech Holdings Company Limited stock trend is positive. The 3 analysts offering 12-month price forecasts for Trevena Inc have a median target of 2. Clovis Oncology Stock Forecast Updated Wed, Apr 19, 2023 3m (0%) 12m (-93. Clovis Oncology (CLVS) stock forecast for 2025 Last update: April 21, 2023 (06:26) Sector: Healthcare The share price of Clovis Oncology, Inc. Stock Forecast & Price Target. 29664 USD Agilent Technologies info Market Cap: 4. CLVS) Stock Forecast & Price ">Clovis Oncology, Inc. Clovis Oncology Stock Price Forecast. The average price target represents a 774. Clovis Oncology (CLVS) Stock Forecast, Price & News Notice: This company has been marked as potentially delisted and may not be actively trading. Clovis Oncology (CLVS) Stock Forecast, Price & News. 123 Share Volume (Previous Close): 5. According to present data Gevo's GEVO shares and potentially its market environment have been in bearish cycle last 12. stock trend is negative. The average twelve-month price prediction for FuelCell Energy is $3. Find company research, competitor information, contact details & financial data for L MAX SERVICES LIMITED PARTNERSHIP of SUNG NOEN, NAKHON RATCHASIMA. Forecasts Financials Shareholders Competitors Stock Price Forecast The 1 analysts offering 12-month price forecasts for Clovis Oncology Inc have a median target of 2. 42% Should I buy or sell NOK stock? All Analysts Top Analysts. CLVS : Clovis Oncology stock forecast 2022 - 2025 - 2030 - AI Pickup. According to the issued ratings of 5 analysts in the last year, the consensus rating for FuelCell Energy stock is Hold based on the current 5 hold ratings for FCEL. According to our research, CLVT stock is a bad long-term investment. Compare Share Today's Range N/A 50-Day Range $0. Clovis Oncology (CLVS) Price Target & Analyst Ratings Notice: This company has been marked as potentially delisted and may not be actively trading. Stock Price Forecast The 1 analysts offering 12-month price forecasts for National Cinemedia Inc have a median target of 0. According to our research, CLXT stock is a bad long-term investment. 85%) (As of 05/9/2023 ET) Compare Today's Range $0. EYEN Signals & Forecast There are few to no technical positive signals at the moment. The Clorox Company (CLX) share price prediction for 2023, 2024, 2025, 2026 and 2027. 46 with a high price target of $4. Clovis Oncology Stock Forecast All Analysts Top Analysts Stock Price Forecast There is currently no analyst price target forecast available for CLVSQ stock. CLVS) Stock Forecast & Price Target. According to our research, CLVS stock is a bad long-term investment. CLVS : Clovis Oncology stock forecast, predictions, and share price target for 2022, 2023 (1 year) to 2025 - 2027 (5 year) to 2030, and 2032 (10 year) with Revenue and EPS Prognosis by Technical Analysis From AI system, total return is. For the next nine years, experts predict that Clovis. CLXT one year forecast. 64% on the last day (Thursday, 11th May 2023) from $4. CLVS Stock 12 Months Forecast. In the next week, the price of CLVS is. The chart below shows the historical price of Clovis Oncology stock and a prediction chart for the next month. CLVS - Clovis Oncology Stock Prediction 2025 - 2030 For Clovis Oncology the 5 year risk analysis shows 4 out of 5 areas green. The Competition Growth & Valuation It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. Dalam kesempatan itu, Jokowi mengungkapkan progres terkini megaproyek tersebut. Weaker technical forecast for Eyenovia Inc. PDF INDONESIA JAVA PREANGER. According to our research, CLVS stock is a bad long-term investment. The average price target is $2. 5338 Forecast data:. 37% on the last trading day (Wednesday, 10th May 2023), rising from $6. 16641 USD 1 Year Forecast: 9. Vertex Energy Inc Stock Forecast, Predictions & Price Target Overview Forecast Earnings Dividend Ownership Analyst price target for VTNR All Analysts Top Analysts Based on 5 analyst s offering 12 month price targets for Vertex Energy Inc. 42 million P/E Ratio N/A Dividend Yield N/A Price. Clarivate Plc stock trend is negative. Functional Foods in Health and Disease 2014; 4(8):340-348 Results : HbA 1c was significantly reduced in delta level (p<0. CLVS : Clovis Oncology stock forecast, predictions, and share price target for 2022, 2023 (1 year) to 2025 - 2027 (5 year) to 2030, and 2032 (10 year) with Revenue and EPS Prognosis by Technical Analysis From AI system, total return is 2366. 427 USD 1 Year Forecast: 1. The average price target is $7. As such, forecasting stock prices is more of an art than a science. However, there are some general principles that can be followed in order to improve the accuracy of stock price predictions. The chart below shows the historical price of Clovis Oncology stock and a prediction chart for the next month. Jokowi: Progres Kereta Api Cepat Jakarta. COM">CLWT stock forecast for 2023 – 2027. us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior. Clovis Oncology stock slides 75% after biotech warns it will run out of cash by January of 2023 Clovis Oncology Inc. CLXT share price has been in a bear cycle for the past year. Calyxt stock monthly and weekly forecasts. 38% change from the last price of $3. BTTX Stock 12 Months Forecast $7. 52 million shs Market Capitalization $9. Thus, just based on the above indication, the company's stock could have 15x upside potential or the price target of $40. 22% Upside) Based on 3 Wall Street analysts offering 12 month price targets for CuriosityStream in the last 3 months. Clovis Oncology Stock Forecast for 2023. It attempts to reflect the cash profit generated by a … Clovis Oncology CLVS. In the last three years, Clovis Oncology's Free Cash Flow has fallen from $-375. Stock Forecast & Price Target">Lexicon Pharmaceuticals (LXRX) Stock Forecast & Price Target. (CLVS) Stock Forecast & Price. Clovis Oncology Inc Stock Forecast, "CLVS" Stock Predictons by …. Calyxt Stock Forecast for 2025: January 2025: 0: 0-100% : CLVS Stock Forecast;. However, there are some general principles that can be followed in order to improve the accuracy of stock price. Positive dynamics for Clovis Oncology shares will prevail with possible volatility of 4. 46% from the current BTTX share price of $0. As such, forecasting stock prices is more of an art than a science. 33 with a high forecast of $10. Forecast target price for 05-19-2023: $ 0. The average price target is $11. CURI Stock 12 Months Forecast $2. LXRX Stock 12 Months Forecast $6. As far as the long-term Clovis Oncology stock forecast is concerned, here's what our predictions are currently suggesting. 901 USD 5 Year Forecast: 3. 06 M Price in USD (Previous Close): 0. 498 USD 1 Year Forecast: 176. According to our research, CLVS stock is a bad long-term investment. Based on 1 Wall Street analysts offering 12 month price targets for Clovis Oncology in the last 3 months. 30 Detailed List of Analyst Forecasts Analyst Performance Analyst Rating Upside / Downside. FuelCell Energy (FCEL) Price Target & Analyst Ratings">FuelCell Energy (FCEL) Price Target & Analyst Ratings. The analysts did not provide CLVS stock price prediction for 2025. For convenience, prices are divided by color. Blue sky scenario: Clovis occupies 75% of the $5 billion (or higher at 27% CAGR) per year PARP inhibitor market in 2025 or after (highly possible with) Lucitanib + Rubraca + Opdivo combination). CLVS stock forecast for 2023 – 2027. Vertex Energy Inc Stock Forecast, Predictions & Price Target Overview Forecast Earnings Dividend Ownership Analyst price target for VTNR All Analysts Top Analysts Based on 5 analyst s offering 12 month price targets for Vertex Energy Inc. stock trend is negative. 76 million shs Market Capitalization $40. "Saya tadi mendapatkan keterangan bahwa progresnya sudah mencapai 88,8% secara keseluruhan," katanya. US Stock Forecast Clovis Oncology Inc Stock Predictons by days: 2022 Search Stock, FX pair, Crypto, or Commodity Clovis Oncology Inc Stock Forecast and Price Prognosis. Clovis Oncology (CLVS) Stock Forecast & Price Prediction 2025, 2030. Clovis Oncology (CLVS) Stock Forecast, Price & News Notice: This company has been marked as potentially delisted and may not be actively trading. Find real-time UXIN - Uxin Ltd stock quotes, company profile, news and forecasts from CNN Business. Clovis Oncology Free Cash Flow Forecast for 2023 - 2025 - 2030. In general, it is important to pay attention to trends, both in the overall market and in the specific sector that a company is in. 88% on the last trading day (Wednesday, 10th May 2023), rising from $4. Detailed values for the Clovis Oncology stock price can be found in the table below. COM">CLXT stock forecast for 2023 – 2027. In the next year, analysts believe that Free Cash Flow will reach $-246. 29 million shs Market Capitalization N/A P/E Ratio N/A. The average price target represents a ― change from the last price of $0. The average price target is $6. Clovis Oncology Stock Forecast Updated Wed, Apr 19, 2023 3m (0%) 12m (-93. Jaguar Health Stock Forecast, Price & News (NASDAQ:JAGX). NASDAQ:XELA Exela Technologies (XELA) Stock Forecast, Price & News $0. Algorithm-based forecasting site Wallet Investor was bearish on the future of Clovis stock. Clovis Oncology Free Cash Flow Forecast for 2023 - 2025 - 2030 In the last three years, Clovis Oncology's Free Cash Flow has fallen from $-375. Clovis Oncology Stock Forecast 2023. Clovis Oncology Stock Forecast, Price & News (NASDAQ:CLVS). 00 and a low forecast of $3. According to our research, CLXT stock is a bad long-term investment. Forecast target price for 05-18-2023: $ 0. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. The Clovis Oncology stock forecast for tomorrow is $ 0. Clovis Oncology (CLVS) stock forecast: Will drug data lift price?. Given the current short-term trend, the stock is expected to rise 73. NASDAQ:JAGX Jaguar Health (JAGX) Stock Forecast, Price & News $0. The MannKind Corporation stock price fell by -3. The MannKind Corporation stock price fell by -3. Jakarta, CNBC Indonesia - Presiden Joko Widodo (Jokowi) meninjau progres perkembangan pembangunan Kereta Api Cepat Jakarta-Bandung (KCJB) di Stasiun Tegal Luar, Kabupaten Bandung, Jawa Barat, Kamis (13/10/2022). 75 with a high forecast of $3. What is BTTX's forecast return on assets (ROA) for 2023-2026? (NASDAQ: BTTX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 0. 00 and a low price target of $3. 15 with a high forecast of $18. LXRX Stock 12 Months Forecast $6. During the last trading day the stock fluctuated 8. CLVS share price has been in a bear cycle for the past year. Clovis Oncology (CLVS) stock forecast for 2027. Stock Forecast & Predictions: 1Y Price Target ">Vertex Energy Stock Forecast & Predictions: 1Y Price Target. In the next week, the price of CLVS is expected to increase by 0. At the end of my 7 days, my credit card will be conveniently charged $397/quarterly (every 3 months) until I cancel. Stock Ahead Of 2022 ">Buying Beaten Down Clovis Oncology Stock Ahead Of 2022. 00 and a low forecast of $4. COM">CLVS stock forecast for 2023 – 2027. 88 million shs Market Capitalization. 04%) Bollinger Bands RSI low/high Values: [ 25 - 75 ] * StockInvest. SunHydrogen Stock Forecast, Price & News (OTCMKTS:HYSR) OTCMKTS:HYSR SunHydrogen (HYSR) Stock Forecast, Price & News $0. (CLVS) Stock Forecast & Price Prediction …. CLVS Stock 12 Months Forecast. com predicts future values using technical analysis of a large number of analytical parameters. Clovis Oncology stock slides 10% premarket after company files for bankruptcy. (CLVS) now CLVS. 36652 USD 5 Year Forecast: 0 USD Agilent Technologies info. 38% Upside) Based on 3 Wall Street analysts offering 12 month price targets for Lexicon Pharmaceuticals in the last 3 months. 38 at the end of this 3-month period. Recommendation Trends No data available Financial Forecast Annual. Clovis Oncology (CLVS) stock forecast for 2025. It projected that shares could drop to 0. 73 Forecast 2030 Underperform TopGraphs Quality. 03 Forecast 2022 $2. 282 USD Agilent Technologies info Market Cap: 20. (CLVSQ) Stock Forecast & Price Targets. The average price target represents a 821. FuelCell Energy (FCEL) Price Target & Analyst Ratings. 15 with a high forecast of $18. Clovis Oncology (CLVS) stock forecast for 2025 Last update: April 21, 2023 (06:26) Sector: Healthcare The share price of Clovis Oncology, Inc. Clovis Oncology Stock Forecast All Analysts Top Analysts Stock Price Forecast There is currently no analyst price target forecast available for CLVSQ stock. Forecast target price for 05-18-2023: $ 0. According to the issued ratings of 5 analysts in the last year, the consensus rating for FuelCell Energy stock is Hold based on the current 5 hold ratings for FCEL. Find company research, competitor information, contact details & financial data for N K MECHATRONICS COMPANY LIMITED of SUNG NOEN, NAKHON RATCHASIMA. Clovis Oncology Free Cash Flow Forecast for 2023 - 2025 - 2030 In the last three years, Clovis Oncology's Free Cash Flow has fallen from $-375. Detailed values for the Clovis Oncology stock price can be found in the table. SunHydrogen Stock Forecast, Price & News (OTCMKTS:HYSR) OTCMKTS:HYSR SunHydrogen (HYSR) Stock Forecast, Price & News $0. 00% gain compared to the current price. INDONESIA JAVA PREANGER REGION: West Java ALTITUDE: 1,200 M - 1,800 M above sea level PROCESS: Washed VARIETAL: Mixed - Typica, Bourbon and S795 HARVEST MONTHS: May to August The story of Java began in 1696 when the mayor of Amsterdam, Nicholas. Stock Price Forecast The 1 analysts offering 12-month price forecasts for Clovis Oncology Inc have a median target of 2. CLXT stock forecast for 2023 – 2027. Clovis Oncology stock slides 10% premarket after company files for bankruptcy. The chart below shows the historical price of Clovis Oncology stock and a prediction chart for the next year. In the next year, analysts believe that Free Cash Flow will reach $. The Vertex stock price gained 4. During the last trading day the stock fluctuated 11. Stock Price Forecast The 4 analysts offering 12-month price forecasts for CuriosityStream Inc have a median target of 2. GEVO Stock 12 Months Forecast. 16 million shs Average Volume 8. 89% change from the last price of $0. 081200, which would represent a 0. GeoEco Journal ISSN: 2460-0768 Vol. L MAX SERVICES LIMITED PARTNERSHIP. As such, forecasting stock prices is more of an art than a science. Lexicon Pharmaceuticals (LXRX) Stock Forecast & Price Target. CLVS : Clovis Oncology stock forecast, predictions, and share price target for 2022, 2023 (1 year) to 2025 - 2027 (5 year) to 2030, and 2032 (10 year) with Revenue and EPS. Caladrius Biosciences Stock Forecast: down to 3. Contents: Long-Term Clovis Oncology Stock Price Predictions Popular CLVS Moving Averages for Fri, Apr 28, 2023 Why Is Clovis Oncology (CLVS) Stock Down 72% Today? Forecasts Clovis Oncology Stock vs. 01% during the next 3 months and, with a 90% probability hold a price between $7. 36% increase from the last price of $1. 22% change from the last price of $0. Clovis Oncology company info Forecasting 52 Week High: 4. Clovis Oncology Stock Forecast Updated Wed, Apr 19, 2023 3m (0%) 12m (-93. com">CLVT stock forecast for 2023 – 2027. Vertex Energy Stock Forecast: up to 10. Calyxt company info Forecasting 52 Week High: 2. The price has been going up and down for this period, and there has been a 11. 00000101 USD 1 Year Forecast: 0. In the TopGraphs chart you can see if NasdaqGS:CLVS is undervalued. Overview Forecast Earnings Dividend Ownership Analyst price target for NOK All Analysts Top Analysts Based on 1 analyst offering 12 month price targets for Nokia Corp. I understand my credit card will be charged $7 today for 7 days of Platinum access. Gevo Inc () Stock Market info Recommendations: Buy or sell Gevo stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Gevo share forecasts, stock quote and buy / sell signals below. The average price target represents a 81. CLVS Stock 12 Months Forecast ― Based on 1 Wall Street analysts offering 12 month price targets for Clovis Oncology in the last 3 months. The price has been going up and down for this period, and there has been a -11.